Drug Trial Radar · NCT06418607
A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants
Last checked: Nov 19, 2026Latest source record: May 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
65
Actual
Start
Jun 23, 2020
Primary completion
Jul 13, 2020
Study completion Jul 13, 2020
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- May 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the bioequivalent effect of venglustat in tablet and hard capsule form when give with water under fasting conditions. Also, to evaluate the safety and tolerability of a single dose tablet and hard capsule of venglustat (swallowed whole) under fasting conditions in healthy adult participants. The maximum duration for participants from screening is up to 47 days.
Conditions
- Healthy Volunteers
Interventions
VenglustatDrug
Pharmaceutical form:Tablet-Route of administration:Oral
VenglustatDrug
Pharmaceutical form:Hard Capsule-Route of administration:Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum plasma concentration observed (Cmax) of venglustatTime frame: Multiple time points up to day 16
- Area under the plasma concentration versus time curve calculated from time zero to the real time (tlast) (AUClast) of venglustatTime frame: Multiple time points up to day 16
- Area under the plasma concentration versus time curve (AUC) of venglustatTime frame: Multiple time points up to day 16
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Clinical Pharmacology of Miami Site Number : 8400001
Miami, Florida
Prism Research Site Number : 8400002
Saint Paul, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.